SummitTX Capital, L.P.

Position in ALKS — Alkermes plc.

CIK 2052310 FORT WORTH, TX

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,031,765

+$1,506,447 QoQ

Shares Held

134,194

-14.1% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#107

of 424 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $15,646,022 across 5 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (44.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc. This page	134,194	$7,031,765
2	AMLX	Amylyx Pharmaceuticals, Inc.	227,690	$4,089,312
3	PRGO	PERRIGO Co plc	231,555	$2,405,856
4	SUPN	Supernus Pharmaceuticals, Inc.	27,151	$1,262,793
5	PBH	Prestige Consumer Healthcare Inc.	18,115	$856,296

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,031,765	134,194	-14.1%	Shares	Sole	2026-08-14
2026-03-31	$5,525,318	156,259	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.